Clinical trial
Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral…
NCT00025402 · III. Medizinische Klinik Mannheim, Other · Unknown status
Key facts
| NCT number | NCT00025402 |
|---|---|
| Title | Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous Leukemia |
| Official title | Randomized Multicenter Treatment Optimization Study In Chronic Myeloid Leukemia (CML) Interferon-a Vs. Allogeneic Stem Cell Transplantation Vs. High-Dose Chemotherapy Followed By Autografting And Interferon-a Maintainance In Early Chronic Phase |
| Lead sponsor | III. Medizinische Klinik Mannheim, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Leukemia |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | filgrastim, recombinant interferon alfa, busulfan, cyclophosphamide, cytarabine, etoposide, hydroxyurea, idarubicin, allogeneic bone marrow transplantation, peripheral blood stem cell transplantation and 1 more |
| Enrollment | 1,000 |
| Start date | Jul 1, 1997 |
| First posted | Jan 27, 2003 |
| Last update posted | Dec 18, 2013 |
| Countries | Czechia, Germany, Poland, Spain, Switzerland |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: